Blueprint Medicines Corporation
—Price / book
Market cap
—
Tangible equity
—
Price / tangible book
—
Price / book
—
Return on equity
-22.5%
Return on assets
-5.7%
Efficiency ratio
—
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: BPMC stock price vs PFG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PFG's multiple
Needs PFG P/B.
Implied fair value · at BPMC's multiple
Needs BPMC P/B.
Metric by metric
Live quote
Price unavailable
Filter, sort, and scan the equity metrics that matter most for banks: book value, tangible book, returns, and operating efficiency.
Lower is better
Lower is better
Profitability lag
Asset efficiency lag
Lower is better
Statements
Bank-focused income statement and equity metrics aligned to the reporting windows.
SEC periods: BPMC FY 2024 (ended Dec 31, 2024) · PFG FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Tangible book and profitability anchor a bank, not enterprise value.
Deposits and cash-like balances distort enterprise value for banks, so this section reads equity value, tangible book and profitability instead.
Price / book
Market cap
—
Tangible equity
—
Price / tangible book
—
Price / book
—
Return on equity
-22.5%
Return on assets
-5.7%
Efficiency ratio
—
Price / book
Market cap
—
Tangible equity
$9.02B
Price / tangible book
—
Price / book
—
Return on equity
10.0%
Return on assets
0.3%
Efficiency ratio
—
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
BLUEPRINT MEDICINES CORPORATION · implied price per share
Bear
$1.09
Base
$1.28
Bull
$1.47
PRINCIPAL FINANCIAL GROUP, INC · implied price per share
Bank model off — standard DCF modelling is disabled for financial institutions.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.01x
0.33x
Net debt / EBITDA
Leverage against operating earnings
-4.24x
-0.30x
Cash and equivalents
Liquid reserves on the balance sheet
$102.01M
$4.43B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider banking comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$1.53M
$3.95B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Price unavailable